Catégories : Tous - trials - production - cancer - facilities

par Sam Garvey Il y a 1 année

127

Europe

Efforts to advance cancer research and treatment are highlighted by multiple clinical trials and expansions in production facilities. These initiatives encompass various types of cancer, including lung, breast, prostate, gastric, and glioblastoma.

Europe

Opened NOVA, world's largest Lu-177 facility in Germany

Opened new Lu-177 production site in Belgium

Announced new N.A. facility dedicated to Lu-177 Production

Lutetium Trials -Prostate -Renal

1 Lutetium trial on NETs (mid-gut) posted as Progenics - bought by Lantheus)

Lantheus

FutureChem

Pilochem | Seibersdorf

Jubliant

2 Trials - Prostate Cancer

Telix Pharma

RadioPharm

2 Trials Lung Cancer (non-small cell) Breast/Gastric Trial not found in database; preclinical

Clinical Trials

Commercial seller

Producer/Manufacturer

Reactor

1 Trial - Solid Tumours Trial not found in database

ImaginAB

Adding 4 production sites in 2023 - 3 commercial supply - 1 research/clinical

"Clinical trials of its therapeutic candidates for solid and hematologic malignancies" Trial not found in database

11 Other Trials: 4 Neuroblastoma/Glioblastoma Nasopharyngeal Cancer Lung Cancer Breast Cancer Merkel Cell Carcinoma Neoplasms Carcinoid Heart Disease 'Solid Tumour' (Novartis acquired Clovis)

13 Prostate 5 under Endocyte (acquired by Novartis)

8 Pancreatic/GEP NETs

1 Lutetium trial - Prostate

4 Lutetium Trials - Prostate Cancer - 3 Prostate - 1 'Select Solid Tumours'

3 Lutetium Trials - 2 GEP NETs - 1 Glioblastoma

Alpha 9 🇨🇦

ISOTOPIA

*building European and Canadian facilities

Point BioPharma

NOVARTIS AAA

Monrol

EZAG

SHINE

BR2 (SCK CEN)

IRE

HFR Petten/PALLAS (NRG)

Curium

FRM-II

ITM